Anticancer Quinolinol Small Molecules Target Multiple Pathways to Promote Cell Death and Eliminate Melanoma Cells Resistant to BRAF Inhibitors
Molecules · 22.06.2025 · 30 (13) · 2696
DOI: 10.3390/molecules30132696 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 22.06.2025. Verfasst von Xinjiang Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA. Hauptthemen laut MEDLINE: Melanoma, Proto-Oncogene Proteins B-raf, Drug Resistance, Neoplasm, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Roswell Park Alliance Foundation, NIGMS NIH HHS.
Abstract (Originalsprache)
Small molecule inhibitors that target the E3 ligase activity of MDM2-MDM4 have been explored to inhibit the oncogenic activity of MDM2-MDM4 complex. MMRi62 is a small molecule that was identified using an MDM2-MDM4 E3 ligase-based high throughput screen and a cell-death-based secondary screen. Our previous studies showed that MMRi62 promotes MDM4 degradation in cells and induces p53-independent apoptosis in cancer cells. However, MMRi62 activity in solid tumor cells such as melanoma cells, especially in BRAF inhibitor resistant melanoma cells, have not been explored. Although its promotion of MDM4 degradation is clear, the direct MMRi62 targets in cells are unknown. In this report, we show that MMRi62 is a much more potent p53-independent apoptosis inducer than conventional MDM2 inhibitors in melanoma cells. A brief structure-activity study led to development of SC-62-1 with improved activity. SC-62-1 potently inhibits and eliminates clonogenic growth of melanoma cells that acquired resistance to BRAF inhibitors. We developed a pair of active and inactive SC-62-1 probes and profiled the cellular targets of SC-62-1 using a chemical biology approach coupled with IonStar/nano-LC/MS analysis. We found that SC-62-1 covalently binds to more than 15 hundred proteins in cells. Pathways analysis showed that SC-62-1 significantly altered several pathways including carbon metabolism, RNA metabolism, amino acid metabolism, translation and cellular response to stress. This study provides mechanistic insights into the mechanisms of action for MMRi62-like quinolinols. This study also suggests multi-targeting compounds like SC-62-1 might be useful for overcoming resistance to BRAF inhibitors for improved melanoma treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
- Department of Chemistry, University at Buffalo, State University of New York, Buffalo, NY 14260, USA.
- Department of Pharmaceutical Sciences, School of Pharmacy, University at Buffalo, State University of New York, Buffalo, NY 14260, USA.
- Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
ORCID-Profile: Xinjiang Wang, Alexis D Kelleher, Erika C Rizzo, Jianmin Wang, Jun Qu
Förderung
- NIH HHS
- Roswell Park Alliance Foundation
- NIGMS NIH HHS
- NATIONAL CANCER INSITUTE (NCI)
- National Institutes of Health
Zitieren
APA
Wang, X., Lama, R., Kelleher, A. D., Rizzo, E. C., Galster, S. L., Xue, C., Zhang, Y., Wang, J., Qu, J., & Chemler, S. R. (2025). Anticancer Quinolinol Small Molecules Target Multiple Pathways to Promote Cell Death and Eliminate Melanoma Cells Resistant to BRAF Inhibitors. Molecules, 30(13), 2696. https://doi.org/10.3390/molecules30132696
Vancouver
Wang X, Lama R, Kelleher AD, Rizzo EC, Galster SL, Xue C, et al. Anticancer Quinolinol Small Molecules Target Multiple Pathways to Promote Cell Death and Eliminate Melanoma Cells Resistant to BRAF Inhibitors. Molecules. 2025;30(13):2696. doi:10.3390/molecules30132696
BibTeX
@article{Wang2025,
author = {Wang, Xinjiang and Lama, Rati and Kelleher, Alexis D and Rizzo, Erika C and Galster, Samuel L and Xue, Chao and Zhang, Yali and Wang, Jianmin and Qu, Jun and Chemler, Sherry R},
title = {Anticancer Quinolinol Small Molecules Target Multiple Pathways to Promote Cell Death and Eliminate Melanoma Cells Resistant to BRAF Inhibitors},
journal = {Molecules},
year = {2025},
volume = {30},
number = {13},
pages = {2696},
doi = {10.3390/molecules30132696}
}
EUVIMED